Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial
- Citation:
- Habib, M. F. O. M., S. Tarek, S. M. E. Teama, K. Ezzat, E. R. M. Boghdadi, A. Marzouk, M. Y. Fouda, S. I. Gawdat, M. M. Bedier, and S. A. W. Amin,
"Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial ",
International Endodontic Journal, vol. 55, issue 11, pp. 1177-1189, 2022.
